In this issue:
Economics of ipilimumab ±talimogene laherparepvec for advanced melanoma
Factors associated with persistent paediatric atopic dermatitis
Topical resiquimod dosing regimens for actinic keratoses
Relative efficacies of systemic atopic dermatitis treatments
Radiation and phototherapies are costeffective for stage IA mycosis fungoides
Generalised severe EBS induces T helper 17 response, and responds to apremilast
Spin in reporting of studies of topical treatments of photoaged skin
Dupilumab for generalised prurigo nodularis
Laser treatments for congenital melanocytic naevi
Hydrochlorothiazide increases Merkel cell carcinoma/malignant adnexal skin tumour risk
Please login below to download this issue (PDF)